Sanjay D Gabhale, Mahavir Satishchand Bagrecha, Mitali Dash, Zeeshan Sheikh, S Bhuvaneshwari, Rangraze Imran, Tharini Satheesh
{"title":"Assessment of Long-Term Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD).","authors":"Sanjay D Gabhale, Mahavir Satishchand Bagrecha, Mitali Dash, Zeeshan Sheikh, S Bhuvaneshwari, Rangraze Imran, Tharini Satheesh","doi":"10.4103/jpbs.jpbs_252_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition portrayed by persistent airflow limitation and correlated symptoms. Despite advances in treatment, COPD remains a significant global health burden, necessitating ongoing research to understand its long-standing impact on pulmonary function and quality of life (QoL).</p><p><strong>Methods: </strong>This longitudinal research enrolled 200 COPD and followed them over a 5-year period. Baseline assessments included spirometry to measure forced expiratory volume in one second (FEV1) and forced vital capacity (FVC), along with standardized questionnaires assessing QoL. Follow-up assessments were conducted annually, and statistical analysis was performed to examine changes in pulmonary function and QoL over time.</p><p><strong>Results: </strong>Significant declines in FEV1 and FVC were observed at each follow-up time point compared to the baseline, indicating progressive deterioration in lung function. QoL scores, as assessed by the St. George's Respiratory Questionnaire and the COPD Assessment Test, also worsened progressively over the research period.</p><p><strong>Conclusion: </strong>Current conclusions underscore the progressive nature of COPD, highlighting the importance of proactive management strategies aimed at preserving lung function and improving QoL. Early intervention and ongoing monitoring are essential in optimizing outcomes for COPD subjects and reducing the disease burden on individuals and healthcare systems.</p>","PeriodicalId":94339,"journal":{"name":"Journal of pharmacy & bioallied sciences","volume":"16 Suppl 3","pages":"S2737-S2739"},"PeriodicalIF":0.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11426579/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy & bioallied sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpbs.jpbs_252_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition portrayed by persistent airflow limitation and correlated symptoms. Despite advances in treatment, COPD remains a significant global health burden, necessitating ongoing research to understand its long-standing impact on pulmonary function and quality of life (QoL).
Methods: This longitudinal research enrolled 200 COPD and followed them over a 5-year period. Baseline assessments included spirometry to measure forced expiratory volume in one second (FEV1) and forced vital capacity (FVC), along with standardized questionnaires assessing QoL. Follow-up assessments were conducted annually, and statistical analysis was performed to examine changes in pulmonary function and QoL over time.
Results: Significant declines in FEV1 and FVC were observed at each follow-up time point compared to the baseline, indicating progressive deterioration in lung function. QoL scores, as assessed by the St. George's Respiratory Questionnaire and the COPD Assessment Test, also worsened progressively over the research period.
Conclusion: Current conclusions underscore the progressive nature of COPD, highlighting the importance of proactive management strategies aimed at preserving lung function and improving QoL. Early intervention and ongoing monitoring are essential in optimizing outcomes for COPD subjects and reducing the disease burden on individuals and healthcare systems.
背景:慢性阻塞性肺疾病(COPD)是一种普遍存在的呼吸系统疾病,表现为持续的气流受限和相关症状。尽管在治疗方面取得了进展,但慢性阻塞性肺病仍然是全球重大的健康负担,因此有必要进行持续研究,以了解其对肺功能和生活质量(QoL)的长期影响:这项纵向研究招募了 200 名慢性阻塞性肺病患者,并对他们进行了为期 5 年的跟踪调查。基线评估包括测量一秒钟用力呼气量(FEV1)和用力肺活量(FVC)的肺活量测定法,以及评估 QoL 的标准化问卷。每年进行一次随访评估,并进行统计分析,以研究肺功能和 QoL 随时间的变化:结果:与基线相比,每个随访时间点的 FEV1 和 FVC 均显著下降,表明肺功能在逐渐恶化。通过圣乔治呼吸问卷和慢性阻塞性肺病评估测试评估的 QoL 分数也在研究期间逐渐恶化:目前的结论强调了慢性阻塞性肺病的渐进性,突出了旨在保护肺功能和改善 QoL 的前瞻性管理策略的重要性。早期干预和持续监测对于优化慢性阻塞性肺病患者的治疗效果、减轻个人和医疗系统的疾病负担至关重要。